| 前收市價 | 44.70 |
| 開市 | 45.30 |
| 買盤 | 38.65 |
| 賣出價 | 43.75 |
| 拍板 | 910.00 |
| 到期日 | 2024-09-20 |
| 今日波幅 | 41.85 - 45.30 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 547 |
Barrons.comEli Lilly’s Weight-Loss Franchise Has Been a Massive Winner Under Dave Ricks
Zepbound and related products could generate more than $50 billion of sales in 2029. There is a lot more in Lilly’s pipeline.
ZacksHere's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
ZacksThe Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.
